MyAverix Finance
TWO · Healthcare
NatureWise Biotech & Medicals Corporation (4732)
Biotechnology
NatureWise Biotech & Medicals Corporation (4732) is listed on TWO in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $986.69M, P/E ratio is 18.00, net margin is -20.5%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 4732
NatureWise Biotech & Medicals Corporation (4732) — FAQ
What is NatureWise Biotech & Medicals Corporation's market cap?
NatureWise Biotech & Medicals Corporation (4732) has a reported market cap of $986.69M (data as of 2026-03-29).
What is 4732's P/E ratio?
The price-to-earnings (P/E) ratio for NatureWise Biotech & Medicals Corporation (4732) is 18.00 (data as of 2026-03-29).
Does NatureWise Biotech & Medicals Corporation pay a dividend?
Dividend yield is not available in the current snapshot for NatureWise Biotech & Medicals Corporation (4732). Check the MyAverix Finance app for the latest dividend data.
What sector is NatureWise Biotech & Medicals Corporation in?
NatureWise Biotech & Medicals Corporation (4732) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 4732 listed on?
4732 is listed on TWO.
What is NatureWise Biotech & Medicals Corporation's net margin?
NatureWise Biotech & Medicals Corporation (4732) reports a net margin of -20.5% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.